Nox4 as a novel target to treat diabetic nephropathy (#90)
Karin AM Jandeleit-Dahm
1
2
,
Jay C Jha
1
2
,
Stephen P Gray
1
,
Cedric Szyndralewiez
3
,
Freddy Heitz
3
,
Mark E Cooper
1
,
Kirstin Wingler
4
,
Harald HHW Schmidt
4
- Baker IDI Heart and Diabetes Institute, Melbourne, VIC, Australia
- Department of Medicine, Monash University, Melbourne, Victoria, Australia
- Genkyotex SA, Geneva, Switzerland
- Cardiovascular Research Institute Maastricht; Faculty of Medicine, Health & Life Science, Maastricht University, Maastricht, Netherlands